Tracon Pharmaceuticals (United States)
- Research works
- 79 ▼ 55% vs 2013–17
- Citations
- 2.7k 34.2 per fractional work
- Top-10% rate
- 39.2% record average 16.5%
- Open access
- 40% world 28%
Not ranked overall: Tracon Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.8×. Every wedge is a field page.
Who are the top researchers at Tracon Pharmaceuticals (United States)?
Ranked on the composite score, Charles P. Theuer lead among researchers whose main affiliation is Tracon Pharmaceuticals (United States).
- 1 Charles P. Theuer United States · #975,123 worldwide 51 citations · 33 works
Which keywords describe research at Tracon Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Cancer Therapy, Inflammation, Immunotherapy, Tumor Microenvironment, Tumor Targeting, Breast Cancer and endothelial progenitor cells.
- Radiopharmaceuticals
- Photodynamic Therapy
- Tumor Metastasis
- Fisheries Sustainability
- Trastuzumab
- HER2
- Cancer Treatment
- Signal Transduction
- Metastatic
- Metastasis
- Cancer Progression
- Targeted Therapy
- Tumor Hypoxia
- Immune Response
- endothelial progenitor cells
- Prognostic Factors
- Breast Cancer
- Tumor Microenvironment
- Immunotherapy
- Inflammation
- Cancer
- Cancer Therapy
- Nanoparticles
- Tumor Targeting
- Chemotherapy
- VEGF
- Angiogenesis
- Oxygen Sensing
- HIF-1
- Warburg Effect
- Epithelial-Mesenchymal Transition
- Cell Proliferation
- PET Imaging
- Drug Delivery
- Glycosylation
- Metastatic Breast Cancer
- Cancer Stem Cells
- Oncogenic Mutations
- BRAF gene
- Radioimmunotherapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer8▲ 7.2×19 topics
- Inflammation7▲ 3.6×18 topics
- Cancer Therapy6▲ 13×12 topics
- Immunotherapy4▲ 8.4×12 topics
- Nanoparticles4▲ 3.9×5 topics
- Tumor Microenvironment4▲ 14×8 topics
- Tumor Targeting4▲ 36×3 topics
- Breast Cancer3▲ 15×3 topics
- Chemotherapy3▲ 5.8×12 topics
- Prognostic Factors3▲ 8.2×6 topics
- VEGF3▲ 110×1 topic
- endothelial progenitor cells3▲ 110×1 topic
- Angiogenesis3▲ 8.9×7 topics
- Immune Response3▲ 5.9×4 topics
- Oxygen Sensing2▲ 22×2 topics
- Tumor Hypoxia2▲ 36×2 topics
- HIF-12▲ 43×1 topic
- Targeted Therapy2▲ 14×4 topics
- Warburg Effect2▲ 43×1 topic
- Cancer Progression2▲ 12×5 topics
- Epithelial-Mesenchymal Transition2▲ 33×3 topics
- Metastasis2▲ 8.5×9 topics
- Cell Proliferation2▲ 31×3 topics
- Metastatic2▲ 44×2 topics
- PET Imaging2▲ 13×3 topics
- Signal Transduction2▲ 11×3 topics
- Drug Delivery2▲ 5.4×3 topics
- Cancer Treatment2▲ 8.8×2 topics
- Glycosylation2▲ 10×2 topics
- HER22▲ 76×1 topic
- Metastatic Breast Cancer2▲ 35×2 topics
- Trastuzumab2▲ 54×1 topic
- Cancer Stem Cells2▲ 49×1 topic
- Fisheries Sustainability2▲ 17×2 topics
- Oncogenic Mutations2▲ 47×2 topics
- Tumor Metastasis2▲ 35×1 topic
- BRAF gene2▲ 115×1 topic
- Photodynamic Therapy2▲ 13×2 topics
- Radioimmunotherapy2▲ 52×1 topic
- Radiopharmaceuticals2▲ 52×1 topic
Which research topics does Tracon Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments, RNA modifications and cancer and Immune Cell Function and Interaction.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 2 Cancer Research and Treatments Biotechnology 1 works
- 3 RNA modifications and cancer Molecular Biology 1 works
- 4 Immune Cell Function and Interaction Immunology 0 works
- 5 Immune cells in cancer Immunology 0 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 7 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
- 8 DNA Repair Mechanisms Molecular Biology 0 works
- 9 Microtubule and mitosis dynamics Cell Biology 0 works
- 10 Glycosylation and Glycoproteins Research Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tracon Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 55% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- University of San Diego
- University of California San Diego Medical Center
- General Atomics (United States)
- Scripps Health
- Naval Medical Center San Diego
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.